Form 8-K - Current report:
SEC Accession No. 0001564590-22-014683
Filing Date
2022-04-19
Accepted
2022-04-19 07:37:12
Documents
12
Period of Report
2022-04-19
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K alks-8k_20220419.htm   iXBRL 8-K 35927
  Complete submission text file 0001564590-22-014683.txt   163837

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA alks-20220419.xsd EX-101.SCH 5589
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE alks-20220419_lab.xml EX-101.LAB 19258
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alks-20220419_pre.xml EX-101.PRE 11468
6 EXTRACTED XBRL INSTANCE DOCUMENT alks-8k_20220419_htm.xml XML 3525
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

IRS No.: 981007018 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35299 | Film No.: 22833477
SIC: 2834 Pharmaceutical Preparations